✦ LIBER ✦

A Phase II Study of Nimustine Hydrochloride, Cisplatin, and Etoposide Combination Chemotherapy for Supratentorial Malignant Gliomas

✍ Scribed by Takaaki Beppu; Yuki Yoshida; Hiroshi Arai; Tsukasa Wada; Michiyasu Suzuki; Akira Ogawa; Seiji Hakozaki; Naohiko Kubo

Book ID: 110235964
Publisher: Springer US
Year: 2000
Tongue: English
Weight: 70 KB
Volume: 49
Category: Article
ISSN: 0167-594X
DOI: 10.1023/a:1006486528418

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II Study of Radiotherapy after H

A Phase II Study of Radiotherapy after Hyperbaric Oxygenation Combined with Interferon-beta and Nimustine Hydrochloride to Treat Supratentorial Malignant Gliomas

✍ Takaaki Beppu; Katsura Kamada; Ryuji Nakamura; Hiroshi Oikawa; Masaru Takeda; Ta 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 160 KB

Combination Chemotherapy Using Carboplat

Combination Chemotherapy Using Carboplatin (JM-8) and Etoposide (JET Therapy) for Recurrent Malignant Gliomas: A Phase II Study

✍ K. Watanabe; H. Kanaya; Y. Fujiyama; P. Kim 📂 Article 📅 2002 🏛 Springer Vienna 🌐 English ⚖ 78 KB

Phase II study of a radiotherapy/etoposi

Phase II study of a radiotherapy/etoposide combination for patients with newly malignant gliomas

✍ P. Beauchesne; C. Soler; P. Rusch; M. J. Fotso; R. Duthel; T. Schmitt; J. Brunon 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 99 KB

Treatment of recurrent malignant suprate

Treatment of recurrent malignant supratentorial gliomas with the association of carboplatin and etoposide: a phase II study

✍ A. Ameri; M. Poisson; L. Chauveinc; Q.M. Chen; JY Delattre 📂 Article 📅 1997 🏛 Springer US 🌐 English ⚖ 29 KB

Intra-arterial Cisplatin Plus Oral Etopo

Intra-arterial Cisplatin Plus Oral Etoposide for the Treatment of Recurrent Malignant Glioma: A Phase II Study

✍ Lynn S. Ashby; William R. Shapiro 📂 Article 📅 2001 🏛 Springer US 🌐 English ⚖ 343 KB

Phase I/II study of a combined gemcitabi

Phase I/II study of a combined gemcitabine, etoposide, and cisplatin chemotherapy regimen for metastatic urothelial carcinoma

✍ Tetsuro Tsukamoto; Junji Yonese; Yuhei Ohkubo; Iwao Fukui 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB

## Abstract ## BACKGROUND The authors attempted to determine the maximum tolerated dose (MTD) of gemcitabine in combination with etoposide and cisplatin as a chemotherapy regimen and investigated the safety and antitumor activity with the recommended doses of gemcitabine with etoposide and cisplat